| Critical role for Gab2 in transformation by BCR/ABL M Sattler, MG Mohi, YB Pride, LR Quinnan, NA Malouf, K Podar, ... Cancer cell 1 (5), 479-492, 2002 | 486 | 2002 |
| Mouse model of Noonan syndrome reveals cell type– and gene dosage–dependent effects of Ptpn11 mutation T Araki, MG Mohi, FA Ismat, RT Bronson, IR Williams, JL Kutok, W Yang, ... Nature medicine 10 (8), 849-857, 2004 | 470 | 2004 |
| The role of Shp2 (PTPN11) in cancer MG Mohi, BG Neel Current opinion in genetics & development 17 (1), 23-30, 2007 | 356 | 2007 |
| Combination of rapamycin and protein tyrosine kinase (PTK) inhibitors for the treatment of leukemias caused by oncogenic PTKs MG Mohi, C Boulton, TL Gu, DW Sternberg, D Neuberg, JD Griffin, ... Proceedings of the National Academy of Sciences 101 (9), 3130-3135, 2004 | 315 | 2004 |
| Prognostic, therapeutic, and mechanistic implications of a mouse model of leukemia evoked by Shp2 (PTPN11) mutations MG Mohi, IR Williams, CR Dearolf, G Chan, JL Kutok, S Cohen, K Morgan, ... Cancer cell 7 (2), 179-191, 2005 | 309 | 2005 |
| Conditional expression of heterozygous or homozygous Jak2V617F from its endogenous promoter induces a polycythemia vera–like disease H Akada, D Yan, H Zou, S Fiering, RE Hutchison, MG Mohi Blood, The Journal of the American Society of Hematology 115 (17), 3589-3597, 2010 | 288 | 2010 |
| JAK2V617F-Mediated Clonal Hematopoiesis Accelerates Pathological Remodeling in Murine Heart Failure S Sano, Y Wang, Y Yura, M Sano, K Oshima, Y Yang, Y Katanasaka, ... Basic to Translational Science 4 (6), 684-697, 2019 | 161 | 2019 |
| Comparison of immune responses in patients infected with Vibrio cholerae O139 and O1 F Qadri, C Wennerås, MJ Albert, J Hossain, K Mannoor, YA Begum, ... Infection and immunity 65 (9), 3571-3576, 1997 | 154 | 1997 |
| Critical requirement for Stat5 in a mouse model of polycythemia vera D Yan, RE Hutchison, G Mohi Blood, The Journal of the American Society of Hematology 119 (15), 3539-3549, 2012 | 143 | 2012 |
| Leukemogenic Ptpn11 causes fatal myeloproliferative disorder via cell-autonomous effects on multiple stages of hematopoiesis G Chan, D Kalaitzidis, T Usenko, JL Kutok, W Yang, MG Mohi, BG Neel Blood, The Journal of the American Society of Hematology 113 (18), 4414-4424, 2009 | 141 | 2009 |
| Comparison of the vibriocidal antibody response in cholera due to Vibrio cholerae O139 Bengal with the response in cholera due to Vibrio cholerae O1 F Qadri, G Mohi, J Hossain, T Azim, AM Khan, MA Salam, RB Sack, ... Clinical Diagnostic Laboratory Immunology 2 (6), 685-688, 1995 | 112 | 1995 |
| Loss of Ezh2 cooperates with Jak2V617F in the development of myelofibrosis in a mouse model of myeloproliferative neoplasm Y Yang, H Akada, D Nath, RE Hutchison, G Mohi Blood, The Journal of the American Society of Hematology 127 (26), 3410-3423, 2016 | 101 | 2016 |
| Critical role of Jak2 in the maintenance and function of adult hematopoietic stem cells H Akada, S Akada, RE Hutchison, K Sakamoto, KU Wagner, G Mohi Stem cells 32 (7), 1878-1889, 2014 | 86 | 2014 |
| Efficacy of vorinostat in a murine model of polycythemia vera H Akada, S Akada, A Gajra, A Bair, S Graziano, RE Hutchison, G Mohi Blood, The Journal of the American Society of Hematology 119 (16), 3779-3789, 2012 | 63 | 2012 |
| Activation and functional analysis of Janus kinase 2 in BA/F3 cells using the coumermycin/gyrase B system MG Mohi, K Arai, S Watanabe Molecular biology of the cell 9 (12), 3299-3308, 1998 | 45 | 1998 |
| Combination of mtor inhibitor and a tyrosine kinase inhibitor for the treatment of neoplasms B Neel, G Mohi US Patent App. 10/520,225, 2006 | 42 | 2006 |
| Phosphatidylinositol 3-kinase p85α subunit-dependent interaction with BCR/ABL-related fusion tyrosine kinases: molecular mechanisms and biological consequences S Ren, E Bolton, MG Mohi, A Morrione, BG Neel, T Skorski Molecular and cellular biology, 2005 | 40 | 2005 |
| Interleukin-1 contributes to clonal expansion and progression of bone marrow fibrosis in JAK2V617F-induced myeloproliferative neoplasm MFU Rahman, Y Yang, BT Le, A Dutta, J Posyniak, P Faughnan, ... Nature Communications 13 (1), 5347, 2022 | 39 | 2022 |
| Differential biological activity of disease-associated JAK2 mutants H Zou, D Yan, G Mohi FEBS letters 585 (7), 1007-1013, 2011 | 38 | 2011 |
| Genetic ablation of Pim1 or pharmacologic inhibition with TP-3654 ameliorates myelofibrosis in murine models A Dutta, D Nath, Y Yang, BT Le, MFU Rahman, P Faughnan, Z Wang, ... Leukemia 36 (3), 746-759, 2022 | 37 | 2022 |
